Related Experiment Video
Updated: May 19, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Vascular disease, ESRD, and death: interpreting competing risk analyses
Morgan E Grams1, Josef Coresh, Dorry L Segev
1Departments of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. mgrams2@jhmi.edu
Vascular disease in chronic kidney disease (CKD) patients increases mortality risk. Competing risk regression offers a more accurate way to estimate absolute risks for end-stage renal disease (ESRD) and death.
Area of Science:
- Nephrology
- Cardiovascular Health
- Biostatistics
Background:
- Vascular disease is a significant predictor of mortality and end-stage renal disease (ESRD) in patients with chronic kidney disease (CKD).
- Accurate estimation of competing risks is crucial for optimal patient management in CKD.
- Understanding the interplay between vascular disease, ESRD, and mortality is essential for improving patient outcomes.
Purpose of the Study:
- To compare standard survival analysis with competing risk regression for estimating absolute risks of ESRD and pre-ESRD mortality in CKD patients.
- To evaluate the association of vascular disease with ESRD and pre-ESRD mortality using different analytical methods.
Main Methods:
- Prospective cohort study utilizing data from the Modification of Diet in Renal Disease (MDRD) study.
- Inclusion of screened (n=885) and randomized (n=837) participants.
- Application of standard survival analysis and competing risk regression to assess outcomes.
Main Results:
- Competing risk regression provided more accurate estimates of absolute risk for ESRD (54%) and pre-ESRD death (29%) at 15 years compared to standard analysis (66% and 51%, respectively).
- Relative risk estimates for the association between vascular disease and pre-ESRD death were similar across both methods.
- Substantial differences in hazard and subhazard ratios were observed for other associations, such as GFR and pre-ESRD mortality.
Conclusions:
- Competing risk regression is superior for estimating absolute risk in the presence of competing events, such as in CKD.
- Vascular disease in CKD patients independently reduces the likelihood of reaching ESRD.
- Careful interpretation of etiologic associations derived from competing risk regression is necessary.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Assumptions of Survival Analysis
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
